From Newmark Property to Hyrdation: 8 IPO listings to watch out for next week

Be the First to Comment Read

From Newmark Property to Hyrdation: 8 IPO listings to watch out for next week

: 8 IPOs to make debut on ASX next week
Image source: eamesBot,


  • The Australian IPO market continues to see a surge in listing activities.
  • More than 30 companies are lined up to make their debut on the ASX this month.
  • 8 IPOs to list on the ASX during the week ended December 10.

From Biome Australia to Alloggio Group, the Australian share market has witnessed more than 20  initial public offering (IPO) listings in the month of November. The action continues with over 30 companies are lined up to commence trading on the Australian Securities Exchange (ASX) this month.

While mineral explorer Cosmos Exploration (ASX: C1X), recycling and packaging business Close the Loop (ASX: CLG), and miner Orange Minerals NL (ASX: OMX) joined the ASX this week, as many as eight companies are in queue to begin public trading on the domestic exchange next week. The list includes American West Metals, Australian Bond Exchange Holdings, The Hydration Pharmaceuticals Company, 5E Advanced Materials Inc, Larvotto Resources, 5E Advanced Materials, Newmark Property REIT, Panther Metals, and Ronin Resources. 

Here’s all you need to know about these forthcoming IPO listings:

Image source: DenPhotos,

Newmark Property REIT

First is property fund manager, Newmark property REIT (ASX: NPR), which is slated to get listed on 6 December. Having pulled back an IPO in March, Newmark is making another attempt to list its shares on the ASX.

The company is eying to raise AU$128.3 million at an offer price of AU$1.9 per share. The stock will have a market capitalisation of AU$344.6 million at the listing.

The company has appointed Credit Suisse, E&P Corporate Advisory, MA Moelis Australia, and Morgan Stanley to manage the offer.

Newmark proposed to issue 67.7 million shares, of which about 75% are expected to come from retail investors, while 25% will stem from institutions.

American West Metals

Next is metal mineral deposits discovery and development company, American West Metals (ASX:AW1), which will list soon its shares on the ASX. The company’s shares are slated to be listed on the domestic bourse on 7 December.

The company had looked to raise up to AU$15 million at 20 cents per share in its initial public offering. The stock will be listed with a market capitalisation of AU$34.9-million if it manages to successfully raise the proposed capital.

Canaccord Genuity was appointed as lead manager to the IPO, which opened for subscription between 8 November and 19 November 2021.

Panther Metals

Nickel, cobalt and gold company, Panther Metals (ASX: PNT) is set to list its shares on the Australian Securities Exchange on December 10. As per the offer document, the company proposes to raise AU$5 million at 20 cents a share in its initial public offering.

It is the Australian subsidiary of London Stock Exchange-listed mineral exploration company, Panther Metals PLC, which focuses on precious metals in Canada and Australia.

Sanlam Private Wealth and Kerr Allan Financial have been appointed as joint lead managers. 

Australian Bond Exchange Holdings

Australian Bond Exchange (ASX: ABE), which offers bond trading, settlement, and custodial services to wholesale investors, is expected to commence trading on the ASX on 6 December 2021.

The company proposed to raise AU$10.4 million in its IPO. It plans to issue 16 million shares at 65 cents each, which would give it a AU$76-million expected market capitalisation at listing.

Stock Marketplace, and Pulse Markets were appointed as lead managers.

ABE was formed in 2015 to provide investors access to the wholesale over-the-counter (OTC) bond market.

The Hydration Pharmaceuticals Company

Consumer products company, The Hydration Pharmaceuticals Company (ASX: HPC), is set to commence trading on the domestic exchange on 9 December 2021.

The company aims to raise as much as AU$17 million via the issuance of new shares at an offer price of 29 cents per share. The offer opened on 11 November and closed on 26 November 2021.

Hydration Pharma is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products in North American markets of Canada and the United States under ‘Hydralyte’ brand. It sells products through a range of retail, e-commerce and direct channels, and outsources manufacturing and supply chain management to a team of valued partners.

Hydralyte North America’s products retain a strong alignment to the World Health Organisation (WHO) formulation for effective healthy hydration products.

Larvotto Resources

Australian copper and gold explorer, Larvotto Resources (ASX:LRV) is all set to list on the ASX under the ticker name, “LRV”.

In the IPO, the company looked to sell up to 30 million shares at an offer price of 20 cents per share to raise up to AU$6 million. The company is expected to begin trading publicly on the ASX on December 6, 2021.

Unlike its name, American West Metals, is an Australian metal mineral explorer and development firm. It has three base metal projects in North America that generate significant resources and mining proposals. The Company has other exploration projects across the US and Canada and focuses on Zinc and copper assets.

Ronin Resources

Mining company Ronin Resources (ASX: RON) is pegged to begin trading publicly on the ASX on 10 December 2021.

The company looked to raise AU$5 million at 20 cents a share via the public listing of its shares. CPS Capital Group was appointed as lead manager to manage the offer. The IPO opened for subscription between 8 November and 29 November 2021.

5E Advanced Materials Inc.

Another mineral explorer 5E Advanced Materials Inc (ASX: ABR), is slated to join the ASX on 9 December. The company is focused on the exploration and development of mineral properties in Australia and the United States.

Last month, the company raised AU$37 million at AU$2.10 per share by the placement of shares to three global institutional investors. The funds will be used to strengthen ABR’s balance sheet ahead of its US listing, as well as to meet general expenses. The fund will be also used to conduct a Bankable Feasibility Study (BFS), advance the value engineering program, and construction of the Fort Cady Integrated Boron Facility located in Southern California, USA.

The company aims to become a fully integrated producer of Boron specialty products, which will be used in the field of the clean energy transition, electric transportation and food security.


Speak your Mind

Featured Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK